Company / Cash per Share
AMICUS THERAPEUTICS, INC. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.72
FY2025
5-year range
$0.53 / $0.94
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
#159 of 205
Health Care
What the data says
AMICUS THERAPEUTICS, INC.'s cash per share of $0.72 is lower than 78% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $0.34 in FY2017 to $1.50 in FY2016.
Based on SEC 10-K filings.
0.72 in FY2025 with a 5-year CAGR of +2.6%.
Declined from $0.88 to $0.72 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +10.3%
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 205This company $0.72 Sector average $72.93
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 1.7% year-over-year.
- Ranks #159 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.72 | -1.7% |
| FY2024 | $0.73 | -17.1% |
| FY2023 | $0.88 | +64.7% |
| FY2022 | $0.53 | -43.0% |
| FY2021 | $0.94 | +48.4% |
| FY2020 | $0.63 | +6.1% |
| FY2019 | $0.59 | +38.4% |
| FY2018 | $0.43 | +24.8% |
| FY2017 | $0.34 | -77.0% |
| FY2016 | $1.50 | +105.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026